Literature DB >> 11794746

Free radical oxidative damage and Alzheimer's disease.

E E Tuppo1, L J Forman.   

Abstract

There is increasing evidence that free radical-induced oxidative damage may play a role in the pathogenesis of Alzheimer's disease. Free radicals are reactive oxygen compounds that may attack and damage lipids, proteins, and DNA. The brain is especially sensitive to oxidative damage because of its high content of readily oxidized fatty acids, high use of oxygen, and low levels of antioxidants. Evidence for oxidative damage has been obtained from postmortem brain tissue as well as from living patients with Alzheimer's disease. Antioxidants such as vitamin E show promise that they may help in treating the disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11794746

Source DB:  PubMed          Journal:  J Am Osteopath Assoc        ISSN: 0098-6151


  19 in total

1.  Novel mechanism of increased Ca2+ release following oxidative stress in neuronal cells involves type 2 inositol-1,4,5-trisphosphate receptors.

Authors:  S Kaja; R S Duncan; S Longoria; J D Hilgenberg; A J Payne; N M Desai; R A Parikh; S L Burroughs; E V Gregg; D L Goad; P Koulen
Journal:  Neuroscience       Date:  2010-11-11       Impact factor: 3.590

2.  Expression of Nrf2 in neurodegenerative diseases.

Authors:  Chenere P Ramsey; Charles A Glass; Marshall B Montgomery; Kathryn A Lindl; Gillian P Ritson; Luis A Chia; Ronald L Hamilton; Charleen T Chu; Kelly L Jordan-Sciutto
Journal:  J Neuropathol Exp Neurol       Date:  2007-01       Impact factor: 3.685

Review 3.  Telomere shortening and Alzheimer's disease.

Authors:  Zhiyou Cai; Liang-Jun Yan; Anna Ratka
Journal:  Neuromolecular Med       Date:  2012-11-16       Impact factor: 3.843

Review 4.  Research progress on flavonoids isolated from traditional Chinese medicine in treatment of Alzheimer's disease.

Authors:  Jianjun Gao; Yoshinori Inagaki; Yang Liu
Journal:  Intractable Rare Dis Res       Date:  2013-02

Review 5.  Early diagnostics and therapeutics for Alzheimer's disease--how early can we get there?

Authors:  Bernhard H Monien; Liana G Apostolova; Gal Bitan
Journal:  Expert Rev Neurother       Date:  2006-09       Impact factor: 4.618

6.  Neural stem cell encapsulation and differentiation in strain promoted crosslinked polyethylene glycol-based hydrogels.

Authors:  Hang Li; Jukuan Zheng; Huifeng Wang; Mathew L Becker; Nic D Leipzig
Journal:  J Biomater Appl       Date:  2018-02-02       Impact factor: 2.646

7.  Homocysteine accumulates in supernatants of stimulated human peripheral blood mononuclear cells.

Authors:  K Schroecksnadel; B Frick; B Wirleitner; H Schennach; D Fuchs
Journal:  Clin Exp Immunol       Date:  2003-10       Impact factor: 4.330

8.  Oxidative damage increased in presenilin1/presenilin2 conditional double knockout mice.

Authors:  Dong-Li Zhang; Yi-Qun Chen; Xu Jiang; Ting-Ting Ji; Bing Mei
Journal:  Neurosci Bull       Date:  2009-06       Impact factor: 5.203

9.  Neuroprotective Effects of Phenolic and Carboxylic Acids on Oxidative Stress-Induced Toxicity in Human Neuroblastoma SH-SY5Y Cells.

Authors:  Naw Hser Gay; Kamonrat Phopin; Wilasinee Suwanjang; Napat Songtawee; Waralee Ruankham; Prapimpun Wongchitrat; Supaluk Prachayasittikul; Virapong Prachayasittikul
Journal:  Neurochem Res       Date:  2018-02-07       Impact factor: 3.996

Review 10.  Antioxidant therapies for Alzheimer's disease.

Authors:  Ye Feng; Xiaochuan Wang
Journal:  Oxid Med Cell Longev       Date:  2012-07-25       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.